Selected article for: "elderly population and population death"

Author: Venosa, Alessandro
Title: Senescence in Pulmonary Fibrosis: Between Aging and Exposure
  • Cord-id: scnf62yq
  • Document date: 2020_11_12
  • ID: scnf62yq
    Snippet: To date, chronic pulmonary pathologies represent the third leading cause of death in the elderly population. Evidence-based projections suggest that >65 (years old) individuals will account for approximately a quarter of the world population before the turn of the century. Genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication
    Document: To date, chronic pulmonary pathologies represent the third leading cause of death in the elderly population. Evidence-based projections suggest that >65 (years old) individuals will account for approximately a quarter of the world population before the turn of the century. Genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication, are described as the nine “hallmarks” that govern cellular fitness. Any deviation from the normal pattern initiates a complex cascade of events culminating to a disease state. This blueprint, originally employed to describe aberrant changes in cancer cells, can be also used to describe aging and fibrosis. Pulmonary fibrosis (PF) is the result of a progressive decline in injury resolution processes stemming from endogenous (physiological decline or somatic mutations) or exogenous stress. Environmental, dietary or occupational exposure accelerates the pathogenesis of a senescent phenotype based on (1) window of exposure; (2) dose, duration, recurrence; and (3) cells type being targeted. As the lung ages, the threshold to generate an irreversibly senescent phenotype is lowered. However, we do not have sufficient knowledge to make accurate predictions. In this review, we provide an assessment of the literature that interrogates lung epithelial, mesenchymal, and immune senescence at the intersection of aging, environmental exposure and pulmonary fibrosis.

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and activation state: 1
    • aberrant activation and active area: 1
    • aberrant activation and activity number: 1
    • aberrant activation and acute lung injury: 1, 2, 3, 4
    • aberrant activation and adaptive immune system: 1
    • aberrant activation and adaptive innate: 1, 2, 3, 4, 5, 6
    • aberrant activation and adaptive innate immunity: 1, 2, 3
    • aberrant activation and adaptive system: 1
    • aberrant activation and lung ability: 1
    • aberrant activation and lung development: 1
    • aberrant activation and lung disease: 1, 2, 3
    • aberrant activation and lung epithelium: 1, 2
    • aberrant activation and lung immune: 1
    • aberrant activation and lung injury: 1, 2, 3, 4, 5, 6, 7
    • aberrant activation and lung macrophage: 1, 2
    • aberrant activation and lung resident: 1
    • aberrant activation and lung response: 1
    • aberrant activation and macrophage activation: 1, 2